Skip to content

Perthes Disease in Norway

A Prospective Nationwide Study of Perthes' Disease in Norway: Functional and Radiographic Outcomes at a Mean Follow-up of Twenty Years

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03885960
Enrollment
216
Registered
2019-03-22
Start date
2018-11-01
Completion date
2025-12-31
Last updated
2025-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Legg Calve Perthes Disease

Keywords

Hip, function, quality of life, osteoarthritis, Perthes, LCPD

Brief summary

Calvé-Legg-Perthes disease (CLP) is a hip disease in children whose femoral head becomes completely or partially necrotic. The disease is most common in five-six years of age. The femoral head is gradually deformed during the active stages of the disease (5-7 years). By healing, the hip joint shape will vary from an approximately normal joint to pronounced changes, the hip joint will be irregular. Such a hip joint is available for osteoarthritis. The purpose of this study is to map the function of the hip, the patient's quality of life and especially the risk factors that affect the outcome of the previous CLP. A nationwide prospective study of CLP was conducted between 1996 and 2000. All children with newly diagnosed Perthes disease (425) were registered. The current study will follow up all these patients with an average follow-up of 20 years. Radiological endpoints are evidence of hip osteoarthritis. Patient-reported outcomes (PROMS) should illuminate the function of the hip and quality of life.

Interventions

None listed

Sponsors

Sophies Minde Ortopedi
CollaboratorINDUSTRY
Oslo University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

\- Subject was diagnosed with Perthes disease between 1996 and 2000 in Norway

Exclusion criteria

* Death upon follow up * Other skeletal dysplasia * Patient not able to give consent,

Design outcomes

Primary

MeasureTime frameDescription
Hip osteoarthritisan average of 20 years follow-upradiographic measurement of weight bearing zone
Hip functionan average of 20 years follow-upPROMS HOOS

Secondary

MeasureTime frameDescription
Hip ROMan average of 20 years follow-upfunctional test of range of motion of the hip
Gluteal muscle strengthan average of 20 years follow-upTrendelenburg test
Hip strengthan average of 20 years follow-upsingle leg hop test - 6 meters

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026